...
elut-img

Elutia Inc., Common Stock

ELUT

NAQ

$3.78

-$0.42

(-10%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$145.16M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
37.22K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.76
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.96 L
$5.24 H
$3.78

About Elutia Inc., Common Stock

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameELUTSectorS&P500
1-Week Return-5.74%-2.06%-0.55%
1-Month Return4.71%-1.92%2.72%
3-Month Return-2.07%-10.4%7.66%
6-Month Return15.6%-4.6%10.15%
1-Year Return94.85%4.06%27.53%
3-Year Return-43.24%1.94%32.31%
5-Year Return-73.93%36.48%89.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue42.90M42.68M47.39M23.85M24.75M[{"date":"2019-12-31","value":90.53,"profit":true},{"date":"2020-12-31","value":90.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.32,"profit":true},{"date":"2023-12-31","value":52.22,"profit":true}]
Cost of Revenue23.13M22.12M28.37M12.21M13.69M[{"date":"2019-12-31","value":81.55,"profit":true},{"date":"2020-12-31","value":77.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.04,"profit":true},{"date":"2023-12-31","value":48.27,"profit":true}]
Gross Profit19.77M20.56M19.02M11.64M11.05M[{"date":"2019-12-31","value":96.14,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":92.51,"profit":true},{"date":"2022-12-31","value":56.61,"profit":true},{"date":"2023-12-31","value":53.76,"profit":true}]
Gross Margin46.08%48.17%40.14%48.80%44.67%[{"date":"2019-12-31","value":94.42,"profit":true},{"date":"2020-12-31","value":98.71,"profit":true},{"date":"2021-12-31","value":82.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.53,"profit":true}]
Operating Expenses51.31M34.16M42.05M41.63M31.59M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.58,"profit":true},{"date":"2021-12-31","value":81.96,"profit":true},{"date":"2022-12-31","value":81.13,"profit":true},{"date":"2023-12-31","value":61.57,"profit":true}]
Operating Income(8.41M)(13.60M)(23.03M)(29.99M)(30.53M)[{"date":"2019-12-31","value":-840900000,"profit":false},{"date":"2020-12-31","value":-1359900000,"profit":false},{"date":"2021-12-31","value":-2303200000,"profit":false},{"date":"2022-12-31","value":-2998900000,"profit":false},{"date":"2023-12-31","value":-3052600000,"profit":false}]
Total Non-Operating Income/Expense(3.50M)(13.83M)(7.07M)(11.44M)(16.49M)[{"date":"2019-12-31","value":-350000000,"profit":false},{"date":"2020-12-31","value":-1383300000,"profit":false},{"date":"2021-12-31","value":-706900000,"profit":false},{"date":"2022-12-31","value":-1144100000,"profit":false},{"date":"2023-12-31","value":-1649100000,"profit":false}]
Pre-Tax Income(11.91M)(21.80M)(24.78M)(36.15M)(41.22M)[{"date":"2019-12-31","value":-1190900000,"profit":false},{"date":"2020-12-31","value":-2179900000,"profit":false},{"date":"2021-12-31","value":-2477700000,"profit":false},{"date":"2022-12-31","value":-3614800000,"profit":false},{"date":"2023-12-31","value":-4122100000,"profit":false}]
Income Taxes30.00K26.00K55.00K34.00K28.00K[{"date":"2019-12-31","value":54.55,"profit":true},{"date":"2020-12-31","value":47.27,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":61.82,"profit":true},{"date":"2023-12-31","value":50.91,"profit":true}]
Income After Taxes(11.94M)(21.82M)(24.83M)(36.18M)(41.25M)[{"date":"2019-12-31","value":-1193900000,"profit":false},{"date":"2020-12-31","value":-2182500000,"profit":false},{"date":"2021-12-31","value":-2483200000,"profit":false},{"date":"2022-12-31","value":-3618200000,"profit":false},{"date":"2023-12-31","value":-4124900000,"profit":false}]
Income From Continuous Operations(11.94M)(21.82M)(24.83M)(32.90M)(41.25M)[{"date":"2019-12-31","value":-1193900000,"profit":false},{"date":"2020-12-31","value":-2182500000,"profit":false},{"date":"2021-12-31","value":-2483200000,"profit":false},{"date":"2022-12-31","value":-3289700000,"profit":false},{"date":"2023-12-31","value":-4124900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(11.94M)(21.82M)(24.83M)(32.90M)(37.66M)[{"date":"2019-12-31","value":-1193900000,"profit":false},{"date":"2020-12-31","value":-2182500000,"profit":false},{"date":"2021-12-31","value":-2483200000,"profit":false},{"date":"2022-12-31","value":-3289700000,"profit":false},{"date":"2023-12-31","value":-3765600000,"profit":false}]
EPS (Diluted)-(17.09)(2.36)(2.40)(2.11)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1709.5,"profit":false},{"date":"2021-12-31","value":-236,"profit":false},{"date":"2022-12-31","value":-240,"profit":false},{"date":"2023-12-31","value":-211,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ELUT
Cash Ratio 0.65
Current Ratio 0.94
Quick Ratio 0.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ELUT
ROA (LTM) -29.16%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ELUT
Debt Ratio Lower is generally better. Negative is bad. 1.83
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.83

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ELUT
Trailing PE NM
Forward PE NM
P/S (TTM) 5.81
P/B 0.00
Price/FCF NM
EV/R 5.75
EV/Ebitda NM

FAQs

What is Elutia Inc. share price today?

Elutia Inc. (ELUT) share price today is $3.78

Can Indians buy Elutia Inc. shares?

Yes, Indians can buy shares of Elutia Inc. (ELUT) on Vested. To buy Elutia Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ELUT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Elutia Inc. be purchased?

Yes, you can purchase fractional shares of Elutia Inc. (ELUT) via the Vested app. You can start investing in Elutia Inc. (ELUT) with a minimum investment of $1.

How to invest in Elutia Inc. shares from India?

You can invest in shares of Elutia Inc. (ELUT) via Vested in three simple steps:

  • Click on Sign Up or Invest in ELUT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Elutia Inc. shares
What is Elutia Inc. 52-week high and low stock price?

The 52-week high price of Elutia Inc. (ELUT) is $5.24. The 52-week low price of Elutia Inc. (ELUT) is $1.96.

What is Elutia Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Elutia Inc. (ELUT) is

What is Elutia Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Elutia Inc. (ELUT) is 0.00

What is Elutia Inc. dividend yield?

The dividend yield of Elutia Inc. (ELUT) is 0.00%

What is the Market Cap of Elutia Inc.?

The market capitalization of Elutia Inc. (ELUT) is $145.16M

What is Elutia Inc.’s stock symbol?

The stock symbol (or ticker) of Elutia Inc. is ELUT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top